INTRODUCTION
Colorectal cancer (CRC) is one of the most common malignancies and a leading cause of cancer-related deaths in Europe and the United States [1] . e 5-year survival rate has been reported to range from 93% in stage I to 95-75% in stage II and 83-44% in stage III tumors [2, 3] . Recent advancements in the diagnosis of CRC and the worldwide diffusion of screening programs have led to an increase in the detection of pathologically T1 (pT1) CRCs [4, 5] . The increasing of early stage CRCs allowed, in the last decades, the development of less invasive treatment including local resections, such as endoscopic mucosal/submucosal dissection (ESD) and transanal endoscopic microsurgery (TEM) in selected rectal cancer patients [6] [7] [8] .
However, the absence of standardized guidelines for indication or contraindications of these treatments, as well as the absence of deep knowledge regarding histopathological parameters of risk recurrence, led to the presentation of some controversial studies reporting high rates of local recurrence a er local excision [9, 10] .
e risk of recurrence is directly related to the risk of residual disease or presence of local lymphatic metastasis. e extent of lymph node impairment has been demonstrated to be between 0 and 12% of T1 CRC patients [11] .
In fact, accurate recommendations strictly guide the choice of local versus radical surgical treatments of pT1 CRC patients, in order to minimize local recurrence due to incomplete lymph node dissection or presence of residual disease. e National Comprehensive Cancer Network (NCCN) [12] colectomy in T1 CRC in the presence of unfavorable macroscopic/endoscopic/histopathological findings such as: sessile polyps, fragmented specimens, positive margins, grade 3-4, angiolymphatic invasion and depth of submucosal invasion [12] .
Consequently, patients with high risk T1 CRC have a good prognosis, and the recurrence rate has been reported to be 1.3% a er radical surgery [13] .
Standard open or laparoscopic colectomies o er on one hand the assured oncologic bene ts, but on the other hand are associated with a not negligible morbidity and mortality rates [14] . For this reason we investigated the role of segmental colectomy (SegCR) as a less invasive, potential alternative treatment in high risk T1 CRC.
We evaluated the outcomes of segmental versus standard colon resection (StaCR) in a matched case-control study, in order to demonstrate if segmental colectomy (ileo-colic resection, sigmoidectomy, segmental transverse colon resection) permits the same short-term and oncological results compared to standard radical colectomy (right and le colectomy, and radical tranverse colectomy).
MATERIAL AND METHODS
One hundred and y three consecutive patients who had undergone surgical resection for a high risk T1 colon cancer were retrospectively reviewed at Sant' Andrea Hospital, Sapienza University of Rome, from April 2003 to September 2012.
T1 colon cancers a er endoscopic removal were de ned as high risk T1, following the NCCN guidelines [12] : sessile polyps, fragmented specimens, grading 3-4, positive margins, angiolymphatic invasion and depth of submucosal invasion (sm2-3).
Fi y-seven colon cancer patients, who had underwent SegCR for high risk T1 tumors were identi ed through a retrospective chart revision.
Segmental colon resection was de ned as follows: ileocolon resection with ligation of peripheral ileo-colic vessels for cecal tumors, sigmoidectomy with sigmoid vessels ligation for sigmoid tumors, segmental transverse colectomy with peripheral mid colon vessels ligation for tumors located in the mid/third transverse colon. e choice to perform SegCR was generally done for elderly patients with a major surgical risk (high comorbidity rate), in order to reduce the operative risk; patients were informed accordingly and an informed consent was obtained.
Standard colon resection was de ned as follows: right colectomy for cecal tumors, le colectomy for sigmoid tumors and transverse colectomy with proximal mid colon vessels ligation and resection of both colon essures for mid transverse colon tumors.
e control patients were obtained by computer matching algorithms from our database containing 96 patients undergoing StaCR for high risk T1 colon cancer between 2003 and 2012.
All resections were performed by experienced colorectal surgeons.
Matching analysis was performed considering sex, age (± 5 years), ASA status, comorbidities, tumor location, grading, type of surgery (open and laparoscopic surgery). After matching analysis, two homogeneous groups of 51 patients were considered for the study.
Follow-up of the patients has been regularly updated by clinical, radiological evaluation and by telephone interviewing yearly by the surgical team, and the last evaluation was conducted on August 2013. Follow-up evaluation has been conducted with the following end-points: overall survival (any case of death), disease speci c survival (death due to colon cancer), and disease free survival ( rst recurrence/relapse a er surgical treatment).
e study was approved by the Ethics Committee. Minimum, maximum and median follow-up were 12, 108 and 57 months, respectively.
Statistics
Statistical analyses were performed using MedCalc for Windows, version 10.2.0.0 (MedCalc So ware, MariaKerke, Belgium). Patient and tumour features were analyzed using means ± SD for quantitative variables, and using frequencies and percentage for categorical variables. Differences in distribution were calculated using the t-test for continuous variables, and chi-square test or Fisher's exact test depending on the number of cases in each subgroup for categorical variables. Survival curves were obtained using the KaplanMeier method and the Log-rank test was used for comparison of groups. e Cox proportional hazards model was used to adjust comparisons. Statistical signi cance was conventionally de ned as p<0.05.
RESULTS
Patient characteristics are outlined in Table I . Any statistical di erence encountered in terms of age, sex, ASA status, comorbidities (Charlson Comorbidity Index), tumor location, grading, type of surgery (open and laparoscopic surgery) between the two groups were noted.
Statistical comparison between the two groups showed that StaCR was performed in a longer operative time than SegCR (123 min vs. 87 min, p < 0.001), and more frequently intraabdominal drains a er StaCR than a er SegCR [45 (88.2%) vs. 31 (60.7%), p<0.01] were positioned. Any signi cant di erence in terms of intra-operative blood loss (114 ml vs. 99 ml, p=0.58) and nasogastric tube placement between the two groups: 35 (68%) vs. 29 (56.8%) (0.63) (Table II) was noted.
Significant differences were found in terms of postoperative outcomes between the two groups; SegCR was associated with a shorter hospital stay than StaCR (6.9 days vs. 8.3 days, p = 0.04), and this was probably due to a longer mean time of the rst stool passage in the StaCR group compared to the SegCR group: 4.2 days vs. 2.5 days (p = 0.03) (Table II) .
e two groups did not di er when morbidity and mortality rates were compared. ere were no signi cant di erences between the two groups in anastomotic leakage or stenosis, post-operative bleeding, wound infection, cardio-pulmonary complications or mortality rate (Table II) When post-operative morbidity was studied by multivariate analysis (multiple logistic regression) the type of resection (SegCR vs. StaCR) was not identi ed as a signi cant predictor factor (Table III) .
When pathological data were analyzed, we found that the mean length of the StaCR specimens was signi cantly higher than the mean length of the SegCR specimens (19 cm vs. 12 cm, p < 0.01) and that the mean number of harvested lymph nodes a er StaCR was signi cantly higher than in the SegCR group (18 vs 10, p < 0.01). However, between the two groups no signi cant di erence was found in terms of the number of positive lymph nodes and nal TNM stage (Table IV) .
Seven patients presented positive lymph nodes (pN1, 4 patients in StaCR group, and 3 patients in SegCR), with a mean number of positive lymph nodes of 1.8. All the patients presenting positive lymph nodes underwent post-operative chemotherapy.
e oncological long-term outcomes were similar between the two groups; only one cancer death was found for both groups (2 patients died of multiple systemic metastasis due to Stage IIIa colon cancers, at 28 and 48 months a er surgical resection) with a 5-year disease-speci c survival of 96% for the StaCR group and 97% for the SegCR group (p = 0.78) (Fig. 1) . Postoperative recurrence occurred in 4 patients (2 cases of hepatic recurrences in both groups, with a 3.9% of recurrence rate). In all cases recurrence was found for patients presenting a stage IIIa colon cancer a er surgical resection. Five-year actuarial overall and disease-free survival for StaCR were similar to SegCR (87% and 95% vs. 88% and 94%, respectively, p = 0.51 and p = 0.33) (Fig. 1) and at the multivariate analysis (Cox regression model) only the number of positive lymph nodes and the stage were demonstrated to signi cantly a ect overall survival and disease free survival. e type of resection was not found to in uence prognosis (Table V) .
DISCUSSION
e National Comprehensive Cancer Network (NCCN) [12] recommends colectomy in T1 colon cancer after endoscopic polypectomy in the presence of unfavorable macroscopic / endoscopic / histopathological ndings (see Methods). Colectomy in these cases is mandatory in order to avoid disease relapse due to incomplete lymph node dissection or presence of residual disease [15, 16] .
Laparoscopic colectomy has permitted, in the last decades, better short-term outcomes compared to open colectomy: laparoscopy in fact o ers a shorter hospital stay, less postoperative pain, better cosmetic outcomes and an early return to patient's normal life compared to the open approach [14, 17, 18] . is is particularly true for le -sided colon cancer, while for a tumor located in the right colon, transverse incision right colectomy seems to o er similar outcomes compared to the laparoscopic approach [19] .
True right and left open/laparoscopic colectomies, however, involve extensive ileo-colic, colon, and colorectal resections associated with classical lymphadenectomies as is recommended for both early and locally advanced right and le colon cancers.
Are these types of resections really necessary even for small pT1 colon cancer, considering also that in 82% of cases definitive pathological examinations after colectomy are negative for residual disease or positive lymph nodes? [20] With this matched case-control study, considering a series of 102 patients, we aimed to compare the short and long-term results of SegCR (ileo-colic resection, segmental transverse resection and sigmoid resection) to StaCR for high risk T1 colon tumors. Our intent was to demonstrate that small, fast and easy colon resections can o er similar oncologic long-term outcomes as in classic standard resections.
is study demonstrated that on one hand, SegCR o ers better short-term outcomes than StaCR, without increasing in post-operative morbidity and mortality rates (faster mean time of rst stool passage and shorter hospital stay, necessitating less intra-abdominal drains), and on the other hand that the actuarial 5-year overall survival, disease free survival, disease specific survival between segmental and standard colon resections are similar.
Segmental colon resection allowed a reduced length of stay, and this is probably due to a reduced operative time and to a prompt return to bowel function. In the present series, in fact, a reduced time of rst stool passage is demonstrated compared to StaCR.
We demonstrated that the e ective long-term oncologic outcomes of open and laparoscopic standard colectomy can be o ered also by SegCR which is able to guarantee better intra-operative and post-operative results compared to StaCR.
e principal argument that can be raised in light of these results is that SegCR is associated with a reduced number of harvested lymph nodes (18 vs. 10, p < 0.01), allowing a potential under-staging of the disease due to an incomplete lymphadenectomy. In the present series, the mean number of positive lymph nodes a er surgery, in StaCR and SegCR was similar (1.75 vs 2, respectively, p = 0.68) and only 4 cancer recurrences were noted at the long-term follow-up (2 for both groups, recurrence rate of 3.9%).
In a population study on 82,896 patients from the SEER database (Surveillance, Epidemiology, and End Results), Chen et al [21] demonstrated that the median survival for Stage I colon cancer with 0 lymph node examined was 132 months compared to 131 months for patients with 8-15 lymph nodes examined. No statistical di erence in survival was also shown between patients with 8 or 9, 10 or 11, and 12 to 14 nodes [21] .
ese results probably demonstrated that for Stage I colon cancer the number of harvested lymph nodes and cut-o of 12 lymph nodes seems not to signi cantly a ect patient's survival [21] .
In the present series, all the patients presenting recurrence were N+, but none had fewer than 10 lymph nodes at the pathological examination. In addition any di erence was found in terms of disease speci c survival and disease-free survival between segmental and standard resections.
e main limitation of this study is that the patients studied are from a single institution. Even if a matched-case control was adopted as the type of study, the retrospective nature and the relatively small sample size precludes the controlled acquisition and real time veri cation of the data that bene t prospective series.
CONCLUSION
e present study demonstrated that limited and segmental open/laparoscopic colon resection can be a safe and e ective alternative to standard resection, o ering better outcomes in terms of short-term results and guaranteeing safe and comparable oncologic long-term outcomes. Further randomized controlled studies are required in order to con rm our data. 
